Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies
- 8 April 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (9) , 2315-2320
- https://doi.org/10.1016/j.bmcl.2005.03.032
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pHFEBS Letters, 2004
- Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivativesBioorganic & Medicinal Chemistry Letters, 2004
- Therapeutic applications of sulfamatesExpert Opinion on Therapeutic Patents, 2004
- Modulation of carbonic anhydrase activity and its applications in therapyExpert Opinion on Therapeutic Patents, 2004
- Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesityExpert Opinion on Therapeutic Patents, 2003
- Oligohydrosis and fever in pediatric patients treated with zonisamidePediatric Neurology, 2003
- Topiramate-Induced NephrolithiasisJournal of Endourology, 2002
- PROCHECK: a program to check the stereochemical quality of protein structuresJournal of Applied Crystallography, 1993
- Importance of the conserved active‐site residues Try7, Glu106 and Thr199 for the catalytic function of human carbonic anhydrase IIEuropean Journal of Biochemistry, 1993
- Binding of sulfonamides to erythrocytes and their components.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989